---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-014379"
form_type: "8-K/A"
ticker: "RMTG"
cik: "0001760026"
company_name: "Regenerative Medical Technology Group Inc."
filed_at: "2022-03-23T23:59:59+00:00"
generated_at: "2026-06-26T19:50:50.668891+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Meso Numismatics completes acquisition of Global Stem Cells Group; financials show $105K net loss

## Summary
- Acquisition closed Aug 18, 2021: Meso Numismatics acquires GCSC for 1M Series AA pref, 8,974 Series DD pref, and $225K.
- Change in control: Benito Novas receives Series AA super-voting stock (67% aggregate vote); CEO Christensen holds 50K Series AA.
- GCSC's audited financials: 2020 revenue $615K (down from $1.02M in 2019), net loss $105K; $461K cash, $459K liabilities.
- Going concern opinion: GCSC has recurring losses and working capital deficit, raising substantial doubt.

## SEC filing metadata
- accession: 0001213900-22-014379
- form_type: 8-K/A
- ticker: RMTG
- cik: 0001760026
- company_name: Regenerative Medical Technology Group Inc.
- filed_at: 2022-03-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.01, 1.01, 3.02, 5.01, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760026/000121390022014379/0001213900-22-014379-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760026/000121390022014379/ea157183-8ka1_meso.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-014379
- JSON: https://secwatch.observer/filing/0001213900-22-014379.json
- Plain text: https://secwatch.observer/filing/0001213900-22-014379.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.